Get all your news in one place.
100’s of premium titles.
One app.
Start reading
Benzinga
Benzinga
Business
Benzinga Insights

12 Health Care Stocks Moving In Friday's Intraday Session

Gainers

  • Unicycive Therapeutics (NASDAQ:UNCY) stock rose 25.3% to $0.81 during Friday's regular session. The current volume of 64.4K shares is 208.0% of Unicycive Therapeutics's average full-day volume over the last 100 days (last updated at 13:30 EST). The company's market cap stands at $12.1 million.
  • TransMedics Group (NASDAQ:TMDX) stock moved upwards by 22.59% to $55.33. Trading volume for TransMedics Group's stock is 1.2 million as of 13:30 EST. This is 277.6% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $1.7 billion. The company's, Q3 earnings came out yesterday.
  • Macrogenics (NASDAQ:MGNX) shares moved upwards by 22.52% to $5.93. The current volume of 1.0 million shares is 128.4% of Macrogenics's average full-day volume over the last 100 days (last updated at 13:30 EST). The market value of their outstanding shares is at $364.4 million. The company's, Q3 earnings came out yesterday.
  • Insulet (NASDAQ:PODD) shares rose 17.62% to $300.35. Trading volume for Insulet's stock is 1.2 million as of 13:30 EST. This is 315.8% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $20.8 billion. As per the news, the Q3 earnings report came out yesterday.
  • Vir Biotechnology (NASDAQ:VIR) stock rose 16.65% to $25.43. Trading volume for Vir Biotechnology's stock is 1.0 million as of 13:30 EST. This is 101.7% of its average full-day volume over the last 100 days. The company's market cap stands at $3.3 billion. As per the news, the Q3 earnings report came out yesterday.
  • Puma Biotechnology (NASDAQ:PBYI) shares rose 15.65% to $2.48. The current volume of 328.0K shares is 180.0% of Puma Biotechnology's average full-day volume over the last 100 days (last updated at 13:30 EST). The market value of their outstanding shares is at $112.7 million. As per the press release, Q3 earnings came out yesterday.

Losers

  • Pulmonx (NASDAQ:LUNG) stock decreased by 66.7% to $4.11 during Friday's regular session. Trading volume for this security as of 13:30 EST is 3.4 million, which is 1075.5% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $153.1 million. As per the news, the Q3 earnings report came out yesterday.
  • Syneos Health (NASDAQ:SYNH) shares fell 47.54% to $25.09. As of 13:30 EST, this security is trading at a volume of 4.8 million shares, making up 633.2% of its average full-day volume over the last 100 days. The company's market cap stands at $2.5 billion. The company's, Q3 earnings came out today.
  • Sensus Healthcare (NASDAQ:SRTS) stock declined by 45.16% to $7.13. As of 13:30 EST, this security is trading at a volume of 2.2 million shares, making up 572.7% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $118.0 million. As per the press release, Q3 earnings came out yesterday.
  • NeuroBo Pharmaceuticals (NASDAQ:NRBO) shares fell 43.15% to $2.65. The current volume of 979.6K shares is 165.3% of NeuroBo Pharmaceuticals's average full-day volume over the last 100 days (last updated at 13:30 EST). The company's market cap stands at $2.3 million.
  • DermTech (NASDAQ:DMTK) shares declined by 42.0% to $1.74. As of 13:30 EST, this security is trading at a volume of 2.2 million shares, making up 490.4% of its average full-day volume over the last 100 days. The company's market cap stands at $52.2 million. As per the press release, Q3 earnings came out yesterday.
  • Vapotherm (NYSE:VAPO) stock fell 37.31% to $0.79. Vapotherm's stock is trading at a volume of 615.3K shares as of 13:30 EST. This is 358.1% of its average full-day volume over the last 100 days. The company's market cap stands at $21.0 million. As per the press release, Q3 earnings came out 2 days ago. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Sign up to read this article
Read news from 100’s of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.